Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

TB-500: Dosage, Benefits, FDA Status & Clinics (2026)

What Is TB-500? TB-500 is a synthetic fragment of thymosin beta-4 — a naturally occurring protein found in virtually every human cell — and it's the piece of that protein that does most of the heavy lifting when it comes to tissue repair. Specifically, it's th

What Is TB-500?

TB-500 is a synthetic fragment of thymosin beta-4 — a naturally occurring protein found in virtually every human cell — and it's the piece of that protein that does most of the heavy lifting when it comes to tissue repair. Specifically, it's the heptapeptide LKKTETQ (amino acids 17 through 23), the actin-binding region that drives cell migration, wound healing, and new blood vessel formation.[1] The full thymosin beta-4 protein has 43 amino acids; TB-500 is a stripped-down version built around the sequence that matters most for recovery.

What makes TB-500 interesting to athletes, injury patients, and researchers is the breadth of what thymosin beta-4 signaling does downstream: angiogenesis, collagen deposition, fibroblast activation, and inflammation control — all processes that determine how fast and how completely tissue heals.[2] The synthetic fragment was originally developed as a veterinary product and has been flagged as a doping substance in equine sports, which tells you something about how seriously the performance world takes it.[1]

Here's the honest reality: the human clinical evidence is thin. Most of the data comes from animal models. TB-500 is not FDA-approved, not available through US compounding pharmacies under current guidance, and is used primarily in research settings or through gray-market channels. If you're reading this page trying to decide whether to use it, the evidence base matters — and you deserve a straight account of what it actually shows.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

TB-500 Dosage Protocols

Beginner Protocol 2 mg twice per week Twice weekly 4-6 weeks (loading), then 2 mg once per week (maintenance) Standard Protocol 2.5 mg twice per week Twice weekly (e.g., Monday and Thursday) 4 weeks loading, 4 weeks maintenance at 2.5 mg/week Advanced Protocol 5 mg twice per week 4 weeks loading, then taper to 2.5 mg/week for 4 weeks Beginner Protocol: Start with the loading phase to saturate tissues. After 4-6 weeks, drop to a maintenance dose. This is the standard protocol used in most community guides. Standard Protocol: Slightly higher loading dose for more significant injuries. Space injections 3-4 days apart for steady levels. Advanced Protocol: For severe injuries or post-surgical recovery. Higher doses are well-tolerated in animal studies but watch for increased fatigue. Often combined with BPC-157 at 500 mcg/day. These are general guidelines for research purposes. Always consult a healthcare professional before use.
02

Question drills

Open a question for its connected answer.

01Frequently Asked Questions About TB-500+

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

SOURCE / peptidemind.com ↗
02What If Histology Shows Disorganized Collagen Despite Faster Closure Rates?+

Faster closure with poor collagen organization suggests TB-500 accelerated contraction without improving matrix quality. This pattern appears when dosing stops too early. TB-500 influences both re-epithelialization (Days 3–7) and collagen remodeling (Days 10–21). If dosing ended at Day 7, the remodeling phase occurred without peptide support. Extend dosing through Day 14 and measure collagen architecture at Day 21 instead.

SOURCE / realpeptides.co ↗
03What If I Accidentally Injected TB-500 Two Hours After Eating?+

Administer the next dose on schedule in a properly fasted state. One mistimed dose reduces that injection's efficacy but doesn't negate cumulative tissue response over a multi-week protocol. Avoid 'makeup' dosing or doubling the next injection. Maintain consistent dosing intervals and timing discipline going forward.

SOURCE / realpeptides.co ↗
04What if I'm considering TB-500 for a partial ACL tear — does the research support its use?+

No human clinical trials have evaluated TB-500 specifically for anterior cruciate ligament tears under controlled conditions. The existing evidence base comes from rat medial collateral ligament models and equine tendon injuries. Neither replicates the biomechanical demands or vascular environment of human knee ligaments. ACL tears involve complex rotational forces and intra-articular healing constraints that animal models with simpler ligament architectures don't capture. If you're exploring peptide-based repair protocols, discuss them with your orthopaedic surgeon in the context of standard surgical versus conservative management timelines. Preclinical animal data isn't sufficient to guide human ACL treatment decisions.

SOURCE / realpeptides.co ↗
05What If I've Had Lateral Epicondylitis for Over a Year — Will TB-500 Still Help?+

Start TB-500 but pair it with shockwave therapy or PRP. Chronic tendinopathy involves collagen cross-linking and fibrosis that peptide therapy alone can't reverse. The peptide improves vascular supply and modulates residual inflammation, which reduces baseline pain, but you won't regain full tensile strength without mechanical disruption of scar tissue. Expect partial improvement (30–50% symptom reduction) rather than complete resolution.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Research Indications

Accelerated healing of muscle fibers with reduced recovery time and enhanced repair via cell migration and differentiation. Connective tissue repair with reduced scar formation and improved biomechanical properties of healing tissues. Enhanced dermal closure, improved angiogenesis, and reduced inflammation in acute and chronic scenarios. Faster recovery from intense training with reduced muscle soreness and improved tissue repair. Strengthened tissues through enhanced repair mechanisms may reduce injury risk. Improved muscle quality through enhanced regeneration and repair pathways. Protective effects against neuronal damage in various models. Preclinical evidence for improved outcomes in spinal injury models. Potential neuroprotective and regenerative effects on brain tissue.

RESEARCH

Research review and sources

Reviewed by: PeptideUniv Research Team Updated: March 26, 2026 Human evidence is limited, so this page leans on early clinical signals, mechanistic work, and preclinical findings rather than settled outcome data.

POTENTIAL BENEFITS

Primary Benefits

Accelerates tissue repair through cell migration and angiogenesis—one of the most effective peptides for injury recovery Regenerates muscle, tendon, and ligament tissue by promoting new blood vessel formation and reducing inflammation Prevents fibroblast-to-myofibroblast conversion, reducing scar tissue formation and preserving tissue flexibility
05

Product & matchup locker

Linked catalog and comparison files.